Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-25

FDA Approved: PALONOSETRON — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for Palonosetron hydrochloride from Apotex Corp., confirming its generic use. Palonosetron is used to prevent chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

SUPPL AP for PALONOSETRON (PALONOSETRON HYDROCHLORIDE)